GENFIT's Elafibranor (Iqirvo®) Granted EU Approval as Pioneer Treatment for PBC Post U.S. FDA Nod
Sep 23, 2024
Biopharmaceuticals Invest Advisor
Three Dynamic Stocks with Million-Dollar Potential from a Modest $1,000 Investment
Mar 25, 2024
Cellectar Biosciences Announces Participation at the 36th Annual Roth Conference
Mar 14, 2024